TMSS Medical College Journal

Basal cell adenoma (BCA) of the salivary gland is a rare neoplasm consists of a monomorphic population of basaloid epithelial cells with occasional inner ductal epithelial cells, arranged in four different cellular growth patterns, described as solid, trabecular, tubular (tubulo-trabecular) and membranous. BCA accounts for 1-2% of all salivary gland tumours. It is predominantly a tumour of major salivary glands with approximately 75-80% of cases found in the parotid glands and at least 5% in the submandibular glands. The patient has no complaints post operatively and maintained routine follow-ups. The Diagnosis is confirmed by post-operative histopathology report. We report a case of BCA of the parotid gland of 25 year old male.

Salivary gland tumors (SGTs) are mostly benign tumors with a strong trend for developing in the major salivary glands, mainly the parotid gland. BCA accounts for 1-2% of all SGTs, and clinically, is slow-growing, asymptomatic, and has well-defned boundaries not exceeding3 cm in diameter. It most frequently develops in adult women older than 50 years. BCA has been acknowledged as a separate entity by World Health Organization (WHO) in the Second Edition of the Salivary Gland Tumours Classification.'? Several sites have been identified in the literature, with the parotid gland being the most frequently reported, followed by the upper lip, buccal mucosa, lower lip, and palate. BCA usually affects people between their fifth and seventh decades of life.” The World Health Organization (WHO) classifies benign salivary gland tumors into 11 different types, including basal cell adenoma (BCA).* BCA carries a favorable prognosis in comparison with other salivary gland neoplasms, especially since recurrence is not common.® Here we are discussing about a male patient of 25 years old.